# Application of the Japanese Verbal Learning Test to Patients With Alzheimer’s Disease in the Early Stage

**Authors:** Mie Matsui, Tadasu Matsuoka, Michio Suzuki

PMC · DOI: 10.7759/cureus.62258 · Cureus · 2024-06-12

## TL;DR

This study shows that the Japanese Verbal Learning Test can detect memory issues in early Alzheimer’s patients.

## Contribution

The study confirms the clinical utility of the Japanese Verbal Learning Test (JVLT-9) for assessing explicit memory in early-stage Alzheimer’s.

## Key findings

- AD patients showed lower immediate recall, learning rate, semantic clustering, and recognition discrimination compared to controls.
- AD patients made significantly more intrusion errors than controls.
- JVLT-9 performance worsened with higher CDR scores, indicating greater dementia severity.

## Abstract

Introduction: This study aimed to investigate the mechanism of memory function in the context of explicit memory in early-stage Alzheimer’s disease (AD) using the short-form Japanese Verbal Learning Test (JVLT-9).

Methods: Participants were 20 patients with early-stage AD and a control group of 23 healthy older adults (normal controls: NC), each of whom was administered the JVLT-9, which is a verbal list learning task used to assess explicit memory comprehensively. Between-group differences for each score were investigated using the Mann-Whitney U test. A two-way analysis of variance (ANOVA) was performed for the number of correct recalls by group (AD/NC) × JVLT-9 task. In addition, the AD group was divided into a CDR 0.5 group and a CDR 1.0 group, and it was performed as a group (CDR 0.5/1.0) × JVLT-9 task two-way ANOVA.

Results: The results demonstrated that the AD group had lower immediate recall, learning rate, semantic clustering, and recognition discrimination and significantly higher intrusion errors compared to the NC group. Further, JVLT-9 recall and recognition rates were found to be lower with higher CDR (an index of dementia severity).

Conclusion: These results are largely consistent with the features of explicit memory in AD reported in the English version, confirming the clinical utility of the JVLT-9 as a test of explicit memory function.

## Linked entities

- **Diseases:** Alzheimer’s disease (MONDO:0004975)

## Full-text entities

- **Diseases:** dementia (MESH:D003704), AD (MESH:D000544)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11245176/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC11245176/full.md

## References

24 references — full list in the complete paper: https://tomesphere.com/paper/PMC11245176/full.md

---
Source: https://tomesphere.com/paper/PMC11245176